The Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted approval to Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec) for treating Duchenne muscular ...

The company reported lower-than-expected revenue for its gene therapy product, Elevidys, in the first quarter of 2025, which amounted to $375 million, falling short of the $444 million forecasted ...

As Japan moves through its ground-breaking biomedical research and regulatory environment, The Japan Cell and Gene Therapy Market is poised for significant growth: between 2023 and 2032, the market is ...

Japan CAR‐T cell therapies market Japan CAR-T Cell Therapies Market grows at 16.3% CAGR, driven by rising cancer cases, R&D, regulatory sup Tuesday, 02 January 2024 12:17 GMT عربي ...

Cellares, in collaboration with Mitsui Fudosan, will establish Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City.

Tokyo - An asylum-seeker collapsed and died after staff at a Japanese immigration centre failed to call for help, allegedly because the doctor was having lunch, a pressure group said on Thursday.